Democratizing Access to Clinical Trials

Jason and Ariana of Sagely Health

In this episode of The Healthcare Theory, we’re joined by Jason Sager, founder of Sagely Health, and Ariana Paness to discuss their groundbreaking work in transforming cancer care.

Sagely Health addresses a critical gap in the healthcare system: the lack of visibility into drugs and clinical trials that target new genetic mutations. Even when a perfect treatment exists, many patients and providers remain unaware of these options. We explore how their platform leverages AI-driven clinical decision support to bridge this knowledge gap, connect patients with life-saving therapies, and empower oncologists to deliver personalized care. Don’t miss this deep dive into the future of precision oncology and the challenges of navigating innovation in cancer treatment.

Timestamps:
00:00 – Podcast and guest introduction
01:05 – Jason’s journey from oncology to founding Sagely Health
02:06 – Ariana’s background and role as a patient advocate
03:37 – The problem: lack of visibility into genetic-specific treatments
05:00 – How Sagely Health uses co-ops to bridge gaps in care
07:26 – Standard of care and its limitations for cancer patients
10:25 – Insights from patient interactions and addressing care gaps
13:41 – Tools and AI used to refine clinical trial searches
18:22 – How Sagely Health empowers patients and collaborates with providers
25:03 – Why Sagely Health chose a direct-to-consumer approach
28:18 – The future of Sagely Health: AI-driven scale and patient focus